CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 70 enrolled
Drug / intervention
Anthocyanin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02536781
NCT02536781Phase 3Completed
CompareCT.gov

Khon Kaen University Ethics Committee in Human Research

Khon Kaen University·interventional·Posted Sep 1, 2015·Updated Aug 2, 2017

In Brief

A Phase 3 clinical trial evaluating Anthocyanin and Placebo for Inflammation of Mouth and Acute Mucous Inflammation. Completed, enrolled 70 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the oral inflammatory reduction effect caused from orthodontic treatment of anthocyanin and placebo mouthrinse.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammation of Mouth, Acute Mucous Inflammation
CountriesThailand
Collaborators--

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedSep 1, 2015
Enrollment StartAug 1, 2015
Primary CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 10.8 years ago

Interventions

Anthocyanindrug

Anti-inflammation gel

Placebodrug

Blank gel